Trial Profile
A 14 day randomized, open label, cross over, single center, outpatient study of Depakote [Divalproex Sodium] delayed-release or Depakote sprinkle vs. divalproex sodium extended-release in child and adolescent patients with epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 17 Apr 2008 New trial record.